Cogstate Limited is a neuroscience technology company specializing in the creation, validation, and commercialization of digital brain health assessments for use in academic and industry-sponsored research worldwide. It offers cognitive services including project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company designs and provides quality assurance services for clinical trials, focusing on the administration, scoring, and recording of conventional brain health assessments. Its technology and services quantify the effects of diseases, drugs, devices, and other interventions on human subjects in clinical trials primarily conducted by pharmaceutical and biotechnology companies. Additionally, Cogstate Limited provides Cognigram, a computerized test aiding healthcare professionals in detecting cognitive decline, along with valid, reliable, and sensitive digital cognitive tests and electronic clinical outcome assessment solutions. It supports endpoint data quality assurance through tailored rater training and strategic central monitoring programs combining operational approaches, advanced analytics, and scientific expertise. Founded in 1999 and headquartered in Melbourne, Australia, Cogstate Limited plays a key role in optimizing cognitive measurements for clinical research and brain health insights.